The TREAT‐NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia

Overview of attention for article published in Human Mutation, August 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 8 X users
patent: 3 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 88 Dimensions

Readers on

mendeley: 101 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT…

Application WO-2023121444-A1

World Intellectual Property Organisation (WIPO)

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WA…

Application WO-2023121445-A1

World Intellectual Property Organisation (WIPO)

TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS

Application WO-2023121446-A1

World Intellectual Property Organisation (WIPO)